Exero Medical, a provider of a wireless post-operative surgical leak, also known as an anastomotic leak, detection medical device system, raised $12.7 million in funding.
This financing includes investments from new investors Longevity Venture Partners, Tech Council Ventures, and Edge Medical Ventures, alongside participation from existing investors.
Mark Kolb, Partner at Tech Council Ventures, adds, “Exero Medical’s breakthrough xBar system has the potential to revolutionize post-operative care by providing critical real-time data to detect complications early—ultimately saving lives and reducing healthcare costs. Tech Council Ventures is proud to support Exero’s growth and expansion into the U.S. market.”
Exero Medical was founded in 2018 by MEDX Xelerator, and is backed by the Israeli Innovation Authority, Tech Council Ventures, Longevity Venture Partners, Edge Medical Ventures, Consensus Business Group (CBG), Unorthodox Ventures, and Clalit Health Services – the largest HMO in Israel.
With fresh funds, Exero Medical intends to commercialize its flagship product, the xBar system – which has been granted Breakthrough Device Designation by the FDA.